Neocis, Inc. appears in FDA device records as the applicant for the Yomi S Robotic System, a next-generation modification of the earlier Yomi Robotic System. The company describes Yomi as a computerized robotic navigational system used in both the planning and surgical phases of dental implantation, intended for partially and fully edentulous adult patients who qualify for dental implants. Public documentation separates the hardware platform from the YomiPlan planning software, and recent clearances have widened the procedural scope of the same robotic platform. [1][3][4][5]
Documented platform and components
The Yomi S Robotic System is described in its user manual as hardware documented under Module I, with a separate YomiPlan graphical user interface used for surgical planning and navigation of anatomical features during surgical execution. The manual defines the end effector as the dental instrument and attachments connected to the guidance arm used to perform dental implant procedures, and references the DICOM imaging standard for patient image files. Neocis publishes the Yomi ecosystem as planning, surgical and restorative features. [2][8][5]
Neocis states that Yomi provides software to preoperatively plan dental implantation procedures and robotic navigational guidance of the surgical instruments, and that the system is intended for partially and fully edentulous adult patients who qualify for dental implants. The company also describes haptic feedback and physical guidance among the features of the original Yomi platform. These are manufacturer descriptions of device function, not independently verified performance results. [4][5]
Regulatory record and dated clearances
FDA records linked by MedtechLedger show K261321 for the Yomi S Robotic System, received April 22, 2026, and decided October 13, 2026, as substantially equivalent under traditional review, with product code QRY and the dental advisory committee. The same record lists the device name as Dental Navigation System, Class II, regulation 872.4120, with a summary statement. [1]
An earlier FDA letter documents K252376 for the Yomi S Robotic System under regulation 21 CFR 872.4120, Bone Cutting Instrument and Accessories, Class II, with product codes PLV and QRY, dated October 28, 2025. That letter states the submission introduced the Yomi S as a next-generation modification of the Yomi Robotic System with no change to intended use compared with the predicate device. A separate FDA record lists K222750 for the Yomi Robotic System, decided December 8, 2022. [3][7]
Pterygoid indication expansion
Neocis announced on October 29, 2026, that Yomi S and YomiPlan received FDA clearance through a 510(k) to specifically support pterygoid implant placement, described by the company as the first and only U.S. clearance for digital guided surgery for pterygoid implants. The announcement frames this as continued indication expansion for the same robotic platform. The company's homepage likewise states that Yomi S is FDA-cleared to support the procedure. [6][5]
Applicant identity and record scope
The applicant name in the FDA records is Neocis, Inc., with a Miami, Florida filing address; that address is a correspondence address in the filings and is not treated here as a verified headquarters. The supplied collection contains one linked 510(k) record, K261321, with a substantially equivalent decision, and the record sample reflects that single entry. These counts describe the retrieved filings as of the snapshot date and do not represent total company sales, total portfolio or safety performance. No parent, brand owner or commercial availability is verified in the sources. [1][3][7]

